To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.

Bill: 116-hr-5587
Sponsor: full_name: Rep. Peterson, Collin C. [D-MN-7]
Introduced: 2020-01-13
Policy area: Health
Subjects: Administrative law and regulatory procedures

Congressional oversight

Drug safety, medical device, and laboratory regulation

Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Food supply, safety, and labeling

Government studies and investigations

State and local government operations
Latest action: action_date: 2020-01-23
text: Referred to the Subcommittee on Biotechnology, Horticulture, and Research.

Summaries:
action_date: 2020-01-13
action_desc: Introduced in House
text: <p>This bill requires the Food and Drug Administration to regulate a hemp-derived cannabidiol (CBD) product as a dietary supplement instead of as a drug. The bill also allows the introduction into interstate commerce of a food with added hemp-derived CBD.</p> <p>The Department of Agriculture must report on market and regulatory barriers for producers operating under its domestic hemp production program.<br /></p> <p />

tv_txt: I 116th CONGRESS 2d Session H. R. 5587 IN THE HOUSE OF REPRESENTATIVES January 13, 2020 Mr. Peterson (for himself, Mr. Comer , Ms. Pingree , and Mr. Massie ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Agriculture , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.

1. Regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances (a) Inclusion in definition of dietary supplement Section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(ff)(3)(B) ) is amended in each of clauses (i) and (ii) by inserting (other than hemp-derived cannabidiol or a hemp-derived cannabidiol containing substance) after an article . (b) Prohibited act Section 301(ll) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331(ll) ) is amended by inserting (other than hemp-derived cannabidiol or a hemp-derived cannabidiol containing substance) after public . 2. Marketability study and report (a) Study The Secretary of Agriculture, in consultation with other relevant Federal and State agencies, shall complete a study on the market and regulatory barriers for producers operating under the domestic hemp production program specified in part 990 of title 7, Code of Federal Regulations (as in effect on the date of enactment of this Act). (b) Contents of study The study under subsection (a) shall include— (1) the costs and requirements for establishing and operating a hemp testing program, including the costs and requirements for operating or contracting with a laboratory approved by the Drug Enforcement Agency; (2) the costs and requirements for the destruction of hemp crops determined to be in excess of 0.3 percent delta-9 tetrahydrocannabinol or opportunities for remediation or alternative uses; (3) the feasibility of producer compliance with sampling timetables; (4) the feasibility of producer compliance with reporting requirements; and (5) other known or potential challenges by the participation of States or producers in the domestic hemp production program. (c) Report Not later than 1 year after the date of the enactment of this Act, the Secretary shall submit a report on the study described in this section to the Committee on Agriculture of the House of Representatives and the Committee on Agriculture, Nutrition, and Forestry of the Senate.